Sequences

Sample result

GLP-1, a diabetes hormone

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

3,061 publications in 1,851 families match these filters.

  1. WO 2008056726-A2008-05-15

    GLP-1 derivatives and the use

    SANWA KAGAKU KENKYUSHO CO LTD

    Query Match 96.3%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  2. JP 2008517055-A2008-05-22

    TRANSEPITHELIAL DELIVERY OF PEPTIDES WITH INCRETIN HORMONE ACTIVITIES

    NITTO DENKO CORPORATION

    Query Match 96.3%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  3. Antidiabetic compounds

    Cadila Healthcare Limited (IN)

    Query Match 96.3%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  4. JP 2008521893-A2008-06-26

    A medical product

    Mederio AG

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 2 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    2 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 31
    

    30 of 30 identical, no gaps.

  5. EP 1938830-A12008-07-02

    Novel exendin agonist compounds

    AMYLIN PHARMACEUTICALS, INC. (US)

    Query Match 96.3%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  6. Glucagon-like protein-1 receptor (glp-1r) agonist compounds

    Covx Technologies Ireland Limited (IE)

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  7. JP 2008530130-A2008-08-07

    GIP ANALOG AND HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES

    AMYLIN PHARMACEUTICALS INC

    Query Match 96.3%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  8. JP 2008538200-A2008-10-16

    Conjugates of a Polypeptide and a Pentasaccharide

    NV Organon

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  9. US 7442680-A2008-10-28

    Inotropic and diuretic effects of GLP-1 and GLP-1 agonists

    Amylin Pharmaceuticals, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  10. JP 2008540402-A2008-11-20

    Novel compounds as GLP-1 Agonists

    Cadila Healthcare Limited

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  11. EP 2001903-A22008-12-17

    Long-acting polypeptides and methods of producing and administering same

    MODIGENE INC

    Query Match 96.3%Identity 100.0%Family of 5

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 5

    Grouped by the same title and applicant. No priority claim is on record.

  12. JP 2009504157-A2009-02-05

    Albumin Fusion Proteins

    Human Genome Sciences Inc

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 86 to 115. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
              ||||||||||||||||||||||||||||||
    Hit    86 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 115
    

    30 of 30 identical, no gaps.

  13. JP 2009504775-A2009-02-05

    METHODS FOR TREATING DIABETES AND REDUCING BODY WEIGHT

    Amylin Pharmaceuticals Inc,Mark Fineman,Leigh MacConell,Kristin Taylor

    Query Match 96.3%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  14. EP 2022505-A22009-02-11

    GLP-1, exendin-4, peptide analogs and uses thereof

    Department of Health and Human Services (US)

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  15. JP 2009513627-A2009-04-02

    BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME

    PEPTRON CO LTD

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  16. Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agent

    Mondobiotech Laboratories AG (LI)

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  17. JP 2009514508-A2009-04-09

    GLP-2 MIMETIBODIES, POLYPEPTIDES, COMPOSITIONS, METHODS AND USES

    CENTOCOR INC

    Query Match 96.3%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, US 60/824160.

  18. METHOS FOR ADMINISTERING LONG-LASTING HYPOGLYCEMIC AGENTS

    GlaxoSmithKline LLC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  19. US 7553940-A2009-06-30

    Long-acting EPO polypeptides and derivatives thereof and methods thereof

    Modigene Inc

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  20. US 7553941-A2009-06-30

    Long-acting polypeptides and methods of producing same

    Modigene Inc

    Query Match 96.3%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  21. EP 2073834-A22009-07-01

    Methods for administering long-lasting hypoglycemic agents

    SMITHKLINE BEECHAM CORP

    Query Match 96.3%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  22. JP 2009525052-A2009-07-09

    LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME

    Fuad FARES,Udi Eyal FIMA

    Query Match 96.3%Identity 100.0%Family of 5

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 5

    Grouped by a shared priority claim, US 60/764761.

  23. US 7566691-A2009-07-28

    Vasoactive intestinal polypeptide pharmaceuticals

    Transition Therapeutics, Inc.

    Query Match 96.3%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  24. US 7576050-A2009-08-18

    GLP-1 exendin-4 peptide analogs and uses thereof

    The United States of America as represented by the Department of Health and Human Services

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  25. JP 2009203235-A2009-09-10

    Food inhibition Agent

    Imperial Collge Innovations Limited,Stephen Robert Bloom, Mohammad Ali Ghatei,Caroline Jane Small,Catherine Louise Dakin

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  26. Peptidomimetics with glucagon antagonistic and glp-1 agonistic activities

    Cadila Healthcare Limited (IN)

    Query Match 96.3%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  27. EP 2120994-A22009-11-25

    Methods and compositions for treating hypoglycemic disorders

    UNIV PENNSYLVANIA

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  28. WO 2009142307-A2009-11-26

    Peptide having activity for extending half-life target peptide in plasma

    Asubio Pharma Co Ltd

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  29. JP 2009542217-A2009-12-03

    GLUCAGON-LIKE PEPTIDES AND USES THEREOF

    Amylin Pharmaceuticals Inc,Richard Pittner,Ved Srivastava,Samuel Janssen

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  30. JP 2010006836-A2010-01-14

    METHOD FOR ADMINISTERING GLP-1 MOLECULES

    EMISPHERE TECHNOLOGIES INC

    Query Match 96.3%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  31. JP 2010500996-A2010-01-14

    DPP-IV RESISTANT GIP HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES

    AMYLIN PHARMACEUTICALS INC

    Query Match 96.3%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  32. US 7666835-B22010-02-23

    Oxyntomodulin for preventing or treating excess weight

    Imperial Innovations Limited

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  33. EP 2157967-A22010-03-03

    SUSPENSION FORMULATIONS OF INSULINOTROPIC PEPTIDES AND USES THEREOF

    INTARCIA THERAPEUTICS INC

    Query Match 96.3%Identity 100.0%Family of 5

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 5

    Grouped by the same title and applicant. No priority claim is on record.

  34. JP 2010090129-A2010-04-22

    GLP-1, EXENDIN-4 PEPTIDE ANALOGS AND USES THEREOF

    The Government of the United States of America as represented by the Secretary Department of Health and Human Services

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  35. JP 2010514835-A2010-05-06

    GLUCAGON-LIKE PROTEIN-1 RECEPTOR (GLP-1R) AGONIST COMPOUNDS

    Curt Bradshaw,Sukumar Sakamuri,Yanwen Fu,Bryan Oates, Joel Desharnais

    Query Match 96.3%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, US 60/879048.

  36. EP 2223938-A12010-09-01

    Derivatives of exendin

    Shanghai Huayi Bio Lab (CN)

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  37. US 7790681-B22010-09-07

    Treatment of cardiac arrhythmias with GLP-1 receptor ligands

    Amylin Pharmaceuticals, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  38. US 7812121-B22010-10-12

    GLP-2 mimetibodies, polypeptides, compositions, methods and uses

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  39. US 7816324-B22010-10-19

    Composition and method for the treatment of diseases affected by a peptide receptor

    Board of Regents, The University of Texas System

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  40. US 7834142-B22010-11-16

    Shortened glucagon-like peptide 1(sGLP-1) preparation method and application

    Dalian D.N. Bio-Engineering Co., Ltd.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  41. US 7847063-B22010-12-07

    GLP-1 derivative

    Sanwa Kagaku Kenkyusho Co., Ltd.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  42. EP 2275117-A12011-01-19

    GLP-1, exendin-4, peptide analogs and uses thereof

    US GOVERNMENT

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  43. JP 2011501959-A2011-01-20

    Albumin Fusion Proteins

    Rosen et al

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 86 to 115. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
              ||||||||||||||||||||||||||||||
    Hit    86 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 115
    

    30 of 30 identical, no gaps.

  44. GLUCAGON-LIKE PEPTIDE-1 RECEPTOR (GLP-1R) AGONISTS FOR TREATING AUTOIMMUNE DISORDERS

    RINAT NEUROSCIENCE CORP

    Query Match 96.3%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  45. EP 2295453-A22011-03-16

    An appetite-suppressing peptide, its compositions and use

    NOVO NORDISK AS

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 7 to 36. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 36
    

    30 of 30 identical, no gaps.

  46. EP 2303313-A22011-04-06

    EXENDINS TO LOWER CHOLESTROL AND TRIGLYCERIDES

    AMYLIN PHARMACEUTICALS INC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  47. US 7928065-B22011-04-19

    Methods of treatment using exendin peptides or GLP-1 peptides

    Amylin Pharmaceuticals, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  48. SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP-1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST

    CADILA HEALTHCARE LTD

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  49. EP 2334316-A12011-06-22

    PROCESS FOR THE SYNTHESIS OF (AIB8,35)HGLP-1(7-36)-NH2

    IPSEN MFG IRELAND LTD

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  50. EP 2343082-A12011-07-13

    Oxyntomodulin for preventing or treating excess weight

    IMP INNOVATIONS LTD

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.